Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
New England Journal of Medicine · 14.11.2024 · 391 (19) · 1773-1786
DOI: 10.1056/nejmoa2408154 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 14.11.2024. Verfasst von Thomas Powles und 25 weiteren Autor:innen. Beteiligte Einrichtung: From Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London (T.P.), the Division of Clini…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Cystectomy, Deoxycytidine. Die Arbeit wurde bisher 459-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: AstraZeneca.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London (T.P.), the Division of Clinical Medicine, School of Medicine and Population Health, University of…
ORCID-Profile: James W F Catto, Hikmat Al-Ahmadie, Ariel G Kann
Förderung
- AstraZeneca
Zitieren
APA
Powles, T., Catto, J. W. F., Galsky, M. D., Al-Ahmadie, H., Meeks, J. J., Nishiyama, H., Vu, T. Q., Antonuzzo, L., Wiechno, P., Atduev, V., Kann, A. G., Kim, T. H., Suárez, C., Chang, C. H., Roghmann, F., Özgüroğlu, M., Eigl, B. J., Oliveira, N., Buchler, T., …, & NIAGARA Investigators (2024). Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer. New England Journal of Medicine, 391(19), 1773-1786. https://doi.org/10.1056/nejmoa2408154
Vancouver
Powles T, Catto JWF, Galsky MD, Al-Ahmadie H, Meeks JJ, Nishiyama H, et al. Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer. New England Journal of Medicine. 2024;391(19):1773-1786. doi:10.1056/nejmoa2408154
BibTeX
@article{Powles2024,
author = {Powles, Thomas and Catto, James W F and Galsky, Matthew D and Al-Ahmadie, Hikmat and Meeks, Joshua J and Nishiyama, Hiroyuki and Vu, Toan Quang and Antonuzzo, Lorenzo and Wiechno, Pawel and Atduev, Vagif and Kann, Ariel G and Kim, Tae-Hwan and Suárez, Cristina and Chang, Chao-Hsiang and Roghmann, Florian and Özgüroğlu, Mustafa and Eigl, Bernhard J and Oliveira, Niara and Buchler, Tomas and Gadot, Moran and Zakharia, Yousef and Armstrong, Jon and Gupta, Ashok and Hois, Stephan and van der Heijden, Michiel S and NIAGARA Investigators, NIAGARA Investigators},
title = {Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {19},
pages = {1773--1786},
doi = {10.1056/nejmoa2408154}
}
EUVIMED